Get my own profile
Public access
View all6 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Andrey LobodaDirector, Computational and Systems Biology, MerckVerified email at merck.com
- Rebecca FitzgeraldProfessor of Cancer Prevention, Cambridge UniversityVerified email at cam.ac.uk
- Paul RejtoExecutive Director, Translational Research, PfizerVerified email at pfizer.com
- Thomas LookProfessor of Pediatrics, Harvard Medical SchoolVerified email at dfci.harvard.edu
- John F. Reilly, Ph.D.Chief Scientific Officer, Nereid TherapeuticsVerified email at nereidtx.com
- Evanthia Galanis, MDProfessor of Medical Oncology, Mayo College of MedicineVerified email at mayo.edu
- Laura Sepp-LorenzinoIntellia TherapeuticsVerified email at intelliatx.com
- Matthew J. Maurer, MS DMScAssociate Professor of Biostatistics and Medicine, Mayo ClinicVerified email at mayo.edu
- Giulio DraettaThe University of Texas MD Anderson Cancer CenterVerified email at mdanderson.org
- Shibing DengPfizerVerified email at pfizer.com
- Guillermo Garcia-ManeroMD Anderson Cancer CenterVerified email at mdanderson.org
- Bernardo RapoportExtraordinary Professor, Department of Immunology, University of Pretoria, South AfricaVerified email at up.ac.za
- Carlos CaldasUniversity of CambridgeVerified email at cruk.cam.ac.uk
- Tao XiePfizerVerified email at pfizer.com
- Nicholas ShannonSingapore General HospitalVerified email at mohh.com.sg
- Randall PetersonUniversity of UtahVerified email at pharm.utah.edu
- Zhengyan 'George' KanDirector of Computational Biology, Pfizer Inc.Verified email at pfizer.com
- Jason ClarkBiometrics Team Leader, AstraZenecaVerified email at astrazeneca.com
- Cong ChenMerck & Co., IncVerified email at merck.com
- Susana RosellóMedical Doctor in Hospital Clinico Universitario of Valencia, SpainVerified email at incliva.es